Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North and South America, Europe and Asia Pacific.

Recent Press Releases

July 25, 2014 - 7:25 a.m.
European CHMP Adopts Positive Opinion for Gilead’s Zydelig® (idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular LymphomaPrinter Friendly Version 

Upcoming Events

Saturday, August 30, 2014 through Wednesday, September 3, 2014
European Society of Cardiology Congress 2014 (ESC)
Thursday, September 4, 2014
Robert W. Baird & Co. 2014 Health Care Conference
Friday, September 5, 2014 through Tuesday, September 9, 2014
54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Saturday, September 6, 2014 through Wednesday, September 10, 2014
European Respiratory Society International Congress 2014 (ERS)
Tuesday, September 9, 2014
2014 Morgan Stanley Global Healthcare Conference

Most Viewed Links

Updated 09/01/14
1.Stock Information
2.SEC Filings
3.Earnings
4.Annual Reports
5.Fundamentals - Snapshot
* Data collected 08/24/14 - 08/31/14

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$107.56
 Stock is Up 0.05 (0.05%)
Data as of 08/29/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Webcast Replay